We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SLS market cap is 119.01M. The company's latest EPS is USD -0.3399 and P/E is -3.77.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.18M | -9.65M | -7.62M | -7.33M | -6.92M |
| Net Income | -8.14M | -9.57M | -7.47M | -7.11M | -6.74M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.9M | 7.6M | 1M | 0 | 0 |
| Operating Income | -16.98M | -19.59M | -41.95M | -37.87M | -31.51M |
| Net Income | -16.76M | -20.7M | -41.3M | -37.34M | -30.88M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.22M | 24.43M | 15.12M | 26.51M | 19.43M |
| Total Liabilities | 14.2M | 14.75M | 12.21M | 10.61M | 9.97M |
| Total Equity | -7.98M | 9.68M | 2.91M | 15.89M | 9.47M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 46.05M | 26.28M | 20.94M | 6.22M | 19.43M |
| Total Liabilities | 18.09M | 5.93M | 16.09M | 14.2M | 9.97M |
| Total Equity | 27.96M | 20.35M | 4.85M | -7.98M | 9.47M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.41M | -10.76M | -20.44M | -28.25M | -35.4M |
| Investing | -5.5M | N/A | N/A | N/A | N/A |
| Financing | 22.32M | 26.65M | 27.06M | 46.75M | 46.76M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.42M | -26.02M | -23.81M | -31.41M | -35.4M |
| Investing | N/A | N/A | -4.5M | -5.5M | N/A |
| Financing | 38.44M | 12.07M | 24.08M | 22.32M | 46.76M |
| Market Cap | 119.01M |
| Price to Earnings Ratio | -3.77 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.37 |
| Price to Book Ratio | 12.29 |
| Dividend Yield | - |
| Shares Outstanding | 90.85M |
| Average Volume (1 week) | 1.56M |
| Average Volume (1 Month) | 1.14M |
| 52 Week Change | -15.48% |
| 52 Week High | 1.84 |
| 52 Week Low | 0.772 |
| Spread (Intraday) | 0.03 (2.29%) |
| Company Name | SELLAS Life Sciences Group Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sellaslifesciences.com/home/default.aspx |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
